Skip To Main Content
Roger Barker on Muck Rack

Roger Barker

As seen in: Color Research & Application, Wiley Online Library, SAGE Publishing, Medscape, Cold Spring Harbor Perspectives in Medicine (Online), NeurologyLive
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Roger

Contact Roger, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Addendum to Dopamine Cell-Based Replacement Therapies

|
By Saeed Kayhanian, Roger Barker, Cambridge Hospitals
| Cold Spring Harbor Perspectives in Medicine (Online)
1,3 1Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 2PY, United Kingdom 2Department of Neurosurgery, Cambridge University Hospitals, Cambridge CB2 0QQ, United Kingdom 3Department of Neurology, Cambridge University Hospitals, Cambridge CB2 0QQ, United Kingdom Correspondence: sk776{at}cam.ac.uk; rab46{at}cam.ac.uk
Open in Who Shared Issue with article?

Stem Cell Therapy for Parkinson’s Disease Reality Check

|
By Indu Subramanian, Roger Barker
| Medscape Verified
This transcript has been edited for clarity. Indu Subramanian, MD: Hello, everyone. Welcome to Medscape. I'm so excited to have Prof Roger Barker here, who is a professor of clinical neuroscience and honorary consultant in neurology at the University of Cambridge in England. I am Indu Subramanian. I work at UCLA, and I'm excited to speak about the very hot topic of stem cells, and specifically today, about stem cells and Parkinson's.
Open in Who Shared Issue with article?

Neurotrophic factors for Parkinson's disease: Current status, progress, and remaining questions. Conclusions from a 2023 workshop

|
By Roger Barker, Mart Saarma, Clive Svendsen, Catherine Morgan
| SAGE Publishing
Declaration of conflicting interests RAB receives grants from Cure Parkinson's, MJ Fox Foundation/ASAP, EU, Rosetrees Trust and the MRC. He has paid consultancies with Aspen Neuroscience, Novo Nordisk, Bluerock Therapeutics, Bayer, UCB, Treefrog therapeutics, Amphista and LifeArc. He received royalties from Wiley and Springer-Nature.
Open in Who Shared Issue with article?
See all 9 licensed articles (22 Total)